This website is intended for US healthcare professionals only.
Contact Us
Contact BioCryst
Submit an Inquiry
Request a Grant or Sponsorship
Expanded-Access Program
Search Medical Information
Clinical Trials
Congresses
Publications
Disease State Information & Resources
Hereditary Angioedema (HAE)
Netherton Syndrome (NS)
Diabetic Macular Edema (DME)
Complement-Mediated Diseases
Clinical Trials
Congresses
Publications
Disease State Information & Resources
Hereditary Angioedema (HAE)
Netherton Syndrome (NS)
Diabetic Macular Edema (DME)
Complement-Mediated Diseases
Contact Us
Contact BioCryst
Submit an Inquiry
Request a Grant or Sponsorship
Expanded-Access Program
Search Medical Information
Physician and Patient Perspectives on the Management of Hereditary Angioedema: A Survey on Treatment Burden and Needs
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Caregivers’ Role in Managing Hereditary Angioedema and Perceptions of Treatment-Related Burdens
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Patient Perspectives on the Treatment Burden of Injectable Medication for Hereditary Angioedema
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Insights into the Treatment Burden of Hereditary Angioedema in the Evolving Treatment Landscape
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Long-Term Prophylaxis in Hereditary Angioedema Management: Current Practices in France and Unmet Needs
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Shared Decision-Making in the Management of Hereditary Angioedema: An Analysis of Patient and Physician Perspectives
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Global Perceptions of the Current and Future Impacts of COVID-19 on Hereditary Angioedema Management
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Berotralstat (BCX7353) is a Novel, Oral Prophylactic Treatment for Hereditary Angioedema: Review of Phase II and III Studies
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Androgen Use in Hereditary Angioedema: A Critical Appraisal and Approaches to Transitioning from Androgens to Other Therapies
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Physician- and patient-reported outcomes by hereditary angioedema type: Data from a real-world study
View Article
biocryst
January 27, 2025
Hereditary Angioedema (HAE)
1
2
Next Page
